SANOFI CONS HEALTHC IND L (SANOFICONR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.409x

Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) has a cash flow conversion efficiency ratio of 0.409x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.57 Billion ≈ $16.97 Million USD) by net assets (Rs3.84 Billion ≈ $41.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SANOFICONR defensive interval ratio to measure how many days the company can operate on defensive assets alone.

SANOFI CONS HEALTHC IND L - Cash Flow Conversion Efficiency Trend (2023–2025)

This chart illustrates how SANOFI CONS HEALTHC IND L's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SANOFI CONS HEALTHC IND L Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SANOFI CONS HEALTHC IND L ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ujjivan Small Finance Bank Limited NSE:UJJIVANSFB	-0.115x
Tourmaline Bio Inc. NASDAQ:TRML	-0.078x
Sino Medical Sciences Technology In SHG:688108	0.030x
Grupo Televisa S.A.B. F:TLV	0.100x
Changzhou Tronly New Electronic Materials Co Ltd SHE:300429	0.043x
Iat Automobile Technology Co Ltd SHE:300825	0.019x
Septerna, Inc. Common Stock NASDAQ:SEPN	0.434x
Chengdu Fusen Noble-House Industrial Co Ltd SHE:002818	0.060x

Annual Cash Flow Conversion Efficiency for SANOFI CONS HEALTHC IND L (2023–2025)

The table below shows the annual cash flow conversion efficiency of SANOFI CONS HEALTHC IND L from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of SANOFI CONS HEALTHC IND L.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Rs3.84 Billion ≈ $41.53 Million	Rs1.88 Billion ≈ $20.33 Million	0.490x	-69.55%
2024-12-31	Rs2.73 Billion ≈ $29.52 Million	Rs4.39 Billion ≈ $47.48 Million	1.608x	+83558.24%
2023-12-31	Rs2.08 Billion ≈ $22.45 Million	Rs-4.00 Million ≈ $-43.26K	-0.002x	--

About SANOFI CONS HEALTHC IND L

NSE:SANOFICONR India Drug Manufacturers - General

Market Cap

$1.23 Billion

Rs113.97 Billion INR

Market Cap Rank

#8176 Global

#395 in India

Share Price

Rs4948.60

Change (1 day)

+4.11%

52-Week Range

Rs3999.50 - Rs5696.00

All Time High

Rs5696.00